MTP Archives - DirectorsTalk

Midatech Pharma Phase I study of MTX-110 in rGB will continue with a planned dose escalation

12th January 2023

Midatech Pharma PLC (LON:MTPH; Nasdaq: MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, has announced that following completion of one month of treatment with MTX-110

Be sure to check our sister interview main ratings news website

MTP

Midatech Pharma Phase I study of MTX-110 in rGB will continue with a planned dose escalation

Q&As

Duke Capital: Equity raise and Growth plans (LON:DUKE)

Cerillion’s Louis Hall on FY results, market potential and future outlook (LON:CER)

Ilika CEO highlights growth, Cirtec partnership and market opportunities (LON:IKA)

Dekel Agri-Vision’s Lincoln Moore on cashew growth and 2025 goals

Touchstone Exploration CEO on Cascadura results, Rio Claro block and 2025 plans (LON:TXP)

ICG Enterprise Trust: Strong portfolio growth, increased investments and resilient strategy

Funds

Positive outlook for European Real Estate financing

Positive outlook for loan markets as conditions improve

TEAM reports strong year-end trading results exceeding expectations

China’s economic recovery gains momentum

UK stocks rally as market confidence rebounds

Nikkei index surges amid renewed optimism

Presentations

Ilika plc: A New Era in Solid-State Battery Innovation – 2024 Investor Presentation

Time Finance PLC Strong Growth and Strategic Progress: A Message from CEO Ed Rimmer

Pulsar Helium Inc.: A Pioneering Force in the Helium Industry with High-Concentration Discoveries

Pennant International Maximising operational efficiency

Norcros Results Year ended 31 March 2024, Strategic Success and Sustainable Growth

SAE Renewables Future Strategy to 2035 and Investment Case by Graham Reid CEO

Broker Talk

Ironveld plc Targets “Sharp Rise” in Cash Flow as £2.5m New Funding Approved, Analyses Turner Pope (LON:IRON)

SAE Renewables Reaches Key Milestone in Battery Storage Innovation, Longspur Research Comments

Norcros plc Strategic Resilience and Growth in Challenging Markets

Cerillion – Impressive Growth Trajectory Bolstered by Strong Full-Year Results highlights Harold Evans Singer

Valeura Energy: “Multiple high impact potential catalysts” set out by Canaccord

Duke Capital: Unlocking growth with strategic equity raise